Skip to main content
    P

    Personalis Inc (PSNL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $15.93
    +0.03 (+0.19%)

    Market Cap: $1.70B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    66%(19/29)
    Avg Surprise
    +6.79%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.25
    Range$-0.32 - $-0.23
    6 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.24-4.8%
    60d ago$-0.250.0%
    30d ago$-0.250.0%
    7d ago$-0.250.0%
    Current$-0.25
    Revenue Consensus
    $21M
    Range$21M - $22M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.28
    Range$-0.43 - $-0.22
    5 analysts
    Revenue Consensus
    $32M
    Range$30M - $33M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.28---
    Sep 26EST
    		-$-0.25---
    Jun 26
    Reported Aug 4
    		$-0.30$-0.25-20.00%Miss-30.4%
    Mar 26
    Reported May 7
    		$-0.29$-0.28-3.57%Miss-61.1%
    Dec 25
    Reported Feb 26
    		$-0.26$-0.31+16.13%Beat-13.0%
    Sep 25
    Reported Nov 4
    		$-0.24$-0.27+11.11%Beat+62.5%
    Jun 25
    Reported Aug 5
    		$-0.23$-0.24+4.17%Beat+4.2%
    Mar 25
    Reported May 6
    		$-0.18$-0.25+28.00%Beat+30.8%
    Dec 24
    Reported Feb 27
    		$-0.23$-0.26+12.88%Beat+57.4%
    Sep 24
    Reported Nov 6
    		$-0.64$-0.34-88.24%Miss-33.3%
    Jun 24
    Reported Aug 7
    		$-0.24$-0.38+36.84%Beat+52.0%
    Mar 24
    Reported May 8
    		$-0.26$-0.38+31.58%Beat+57.4%
    Dec 23
    Reported Feb 28
    		$-0.54$-0.50-8.00%Miss+19.4%
    Sep 23
    Reported Nov 7
    		$-0.48$-0.52+7.69%Beat+17.2%
    Jun 23
    Reported Aug 8
    		$-0.50$-0.54+7.41%Beat+16.7%
    Mar 23
    Reported May 3
    		$-0.61$-0.58-5.17%Miss+3.2%
    Dec 22
    Reported Feb 23
    		$-0.67$-0.64-4.69%Miss-48.9%
    Sep 22
    Reported Nov 2
    		$-0.58$-0.63+7.94%Beat-45.0%
    Jun 22
    Reported Aug 3
    		$-0.60$-0.58-3.45%Miss-76.5%
    Mar 22
    Reported May 4
    		$-0.63$-0.58-8.62%Miss-117.2%
    Dec 21
    Reported Feb 24
    		$-0.45$-0.50+10.00%Beat-32.4%
    Sep 21
    Reported Nov 4
    		$-0.40$-0.42+4.76%Beat-48.1%
    Jun 21
    Reported Aug 4
    		$-0.34$-0.39+12.82%Beat-17.2%
    Mar 21
    Reported May 5
    		$-0.29$-0.36+19.44%Beat+0.0%
    Dec 20
    Reported Feb 25
    		$-0.34$-0.29-17.24%Miss-750.0%
    Sep 20
    Reported Nov 5
    		$-0.27$-0.28+3.57%Beat-58.8%
    Jun 20
    Reported Aug 6
    		$-0.29$-0.34+14.71%Beat-52.6%
    Mar 20
    Reported May 7
    		$-0.29$-0.25-16.00%Miss+58.6%
    Dec 19
    Reported Mar 25
    		$-0.04N/A+84.00%Beat-
    Sep 19
    Reported Nov 13
    		$-0.17$-0.25+32.00%Beat-
    Jun 19
    Reported Aug 13
    		$-0.19$-0.26+26.92%Beat-
    Mar 19
    Reported Jun 20
    		$-0.70$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-14.61EV/EBITDAN/A
    Price/FCF-16.63xFCF Yield-6.01%
    Profitability
    Profit Margin-153.80%Operating Margin-150.20%
    ROE-50.30%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-536.72x
    Current Ratio5.28xQuick Ratio5.08x
    Trading Statistics
    Beta2.32Avg Volume2.30M
    52-Week High$18.8952-Week Low$4.96

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$16.02
    SMA 20$16.19
    SMA 50$16.02
    SMA 200$10.88
    EMA 10$16.01
    EMA 20$16.09
    EMA 50$15.58
    EMA 200$11.88

    MACD

    Line: -0.04Signal: 0.04Hist: -0.08

    ADX

    ADX: 18.9+DI: 15.6-DI: 17.5

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down96.0
    PSAR$16.52

    Bollinger Bands

    Upper Band$16.64
    Lower Band$15.74
    %B Position554%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    46.7

    Momentum Oscillators

    Stoch %K21.1
    Stoch %D18.4
    Williams %R-72.5
    ROC (10d)-1.5%
    Momentum-0.24
    CCI (20d)-95.6
    MFI (14d)32.0

    Volatility Measures

    ATR (14d)$0.42(2.7%)
    StdDev (20d)0.22
    Hist Vol13.8%(Low)

    Volume Flow

    VWAP$15.95
    OBV101.3M
    AD Line37.8M
    CMF (20d)-0.003

    Volume Metrics

    Avg Vol (20d)2.1M
    Vol Ratio1.0x
    VWMA (20d)$16.12

    Pivot Points

    R3$16.36
    R2$16.18
    R1$16.04
    Pivot Point$15.86
    S1$15.72
    S2$15.54
    S3$15.40

    Advanced Oscillators

    TSI-2.80
    Ultimate Osc43.3
    KST-11.31

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$22.36M$15.47M$17.34M$14.49M$17.20M$20.61M$16.80M$25.71M$22.58M$19.52M$19.68M$18.25M
    Cost of Revenue$17.61M$15.19M$15.45M$12.58M$12.45M$13.40M$12.25M$16.96M$14.54M$14.03M$14.47M$14.77M
    Gross Profit$4.74M$281,000$1.90M$1.91M$4.76M$7.21M$4.55M$8.74M$8.04M$5.49M$5.21M$3.48M
    Operating Expenses$38.33M$32.44M$27.17M$25.20M$26.56M$24.90M$22.66M$23.13M$24.93M$24.37M$29.18M$34.27M
    R&D$16.34M$14.54M$13.07M$12.17M$12.38M$12.64M$11.49M$11.68M$12.96M$12.77M$13.61M$16.74M
    SG&A$22.00M$17.90M$14.09M$13.03M$14.18M$12.26M$11.17M$11.44M$11.97M$11.60M$11.52M$11.97M
    Operating Income$-33,591,000$-32,161,000$-25,266,000$-23,291,000$-21,804,000$-17,696,000$-18,112,000$-14,382,000$-16,893,000$-18,880,000$-23,972,000$-30,793,000
    Interest Income$1.97M$2.17M$1.57M$1.68M$1.88M$2.03M$1.63M$1.38M$1.14M$1.36M$1.48M$1.71M
    Interest Expense$37,000$47,000$65,000$64,000$48,000$28,000$-1,000$7,000$9,000$9,000$9,000$15,000
    Income Before Tax$-31,678,000$-30,016,000$-23,803,000$-21,649,000$-20,054,000$-15,743,000$-16,421,000$-39,086,000$-12,798,000$-12,961,000$-26,579,000$-29,070,000
    Income Tax Expense$5,000$16,000$9,000$3,000$2,000$7,000$4,000$3,000$4,000$7,000$5,000$28,000
    Net Income$-31,683,000$-30,032,000$-23,812,000$-21,652,000$-20,056,000$-15,750,000$-16,425,000$-39,089,000$-12,802,000$-12,968,000$-26,584,000$-29,098,000
    EBITDA$-32,259,000$-30,895,000$-23,691,000$-21,741,000$-20,473,000$-16,239,000$-16,351,000$-38,267,000$-11,663,000$-12,197,000$-25,740,000$-28,662,000
    EBIT$-33,607,000$-32,141,000$-25,308,000$-23,265,000$-21,884,000$-17,742,000$-18,053,000$-40,463,000$-13,925,000$-14,311,000$-28,047,000$-30,761,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PSNL

    Government Contracts

    Gov Obligations (TTM)
    $13.50M
    Gov Obligations / Revenue
    20.9%
    Obligations YoY
    72.3%
    Active Awards
    3
    New Awards (TTM)
    1
    Avg Remaining Term
    1.8 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24E25N0228Department of Veterans AffairsDepartment of Veterans Affairs$13.50MSep 30, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Tracking Cathie Wood: A Major Add to Recursion Pharmaceuticals, Trimming Personalis and Platform-Tech Exposure

    Cathie Wood's ARK Invest has strategically rebalanced its portfolio, significantly increasing its stake in Recursion Pharmaceuticals and other AI-driven drug discovery, compute...

    Moomoo•10/16/26•Neutral

    Tracking Cathie Wood: Adding Freenome and AI Compute, Cutting Personalis and Toast

    On October 13, 2026, Cathie Wood's ARK Invest showed a trading pattern characterized by a rotation towards precision medicine, AI compute, and autonomous systems, funded by reductions in diagnostics, fintech...

    Moomoo•10/14/26•Bearish

    Personalis (PSNL) On Tempus Deal Optimism Looks Slightly Pricey

    Personalis (PSNL) stock has seen significant year-to-date gains but recent trading suggests potential overvaluation. While the company's strategic partnerships, particularly with Tempus AI...

    Simply Wall Street•10/8/26•Somewhat-Bearish

    Tempus AI, Personalis saw US merger antitrust waiting period expire

    The US merger antitrust waiting period for the deal between biotechnology firms Tempus AI and Personalis expired on October 2...

    MLex•10/6/26•Somewhat-Bullish

    A 30-day merger waiting period ends for Personalis (PSNL) and its proposed acquirer.

    The Hart-Scott-Rodino waiting period for Personalis Inc.'s (PSNL) proposed merger with Tempus AI expired on October 2, 2026. This expiration means a key regulatory hurdle has been cleared...

    Stock Titan•10/6/26•Somewhat-Bullish

    PSNL Valuation and Fair Value

    P/E
    -14.6x
    P/FCF
    -16.6x
    P/B
    7.1x
    See GNG's fair value

    PSNL Profitability: Margins, ROIC and FCF

    Gross margin
    12.7%
    Operating margin
    -150.2%
    Net margin
    -153.8%
    ROE
    -50.3%
    FCF margin
    -144.9%
    FCF yield
    -6.0%

    PSNL Competitors

    CompanyTicker
    Trevi Therapeutics IncTRVI
    Septerna, Inc. Common StockSEPN
    Alignment Healthcare LLCALHC
    Dentsply Sirona IncXRAY
    Sonida Senior Living IncSNDA
    Intellia Therapeutics IncNTLA
    Xencor IncXNCR
    Novocure LtdNVCR

    Sector: Healthcare

    PSNL Analyst Ratings

    Consensus
    Hold
    Analysts
    5
    Strong Buy
    0
    Buy
    2
    Hold
    3
    Sell
    0
    Strong Sell
    0

    PSNL Bull Case vs Bear Case

    Bull case

    • PSNL grew quarterly revenue 30.0% year over year.

    Bear case

    • PSNL has a -153.8% net profit margin.

    PSNL Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -4.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.25
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About PSNL

    Does PSNL pay dividends?

    Personalis Inc (PSNL) does not currently pay a regular dividend.

    What is PSNL's market cap?

    Personalis Inc (PSNL) has a market capitalization of $1.70B with a current stock price of $15.93.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In